M 177 Pill - white round, 12mm
Pill with imprint M 177 is White, Round and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc.
Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Migraine Prevention; Seizures; Epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 177
![Divalproex sodium extended-release 250 mg M 177](https://www.drugs.com/images/pills/nlm/510790766.jpg)
![Divalproex sodium extended-release 250 mg M 177](https://www.drugs.com/images/pills/nlm/003780472.jpg)
![Divalproex sodium extended-release 250 mg M 177 Front](https://www.drugs.com/images/pills/mmx/t109047f/divalproex-sodium-extended-release.jpg)
![Divalproex sodium extended-release 250 mg M 177 Back](https://www.drugs.com/images/pills/mmx/t109047b/divalproex-sodium-extended-release.jpg)
![Divalproex sodium extended-release 250 mg M 177](https://www.drugs.com/images/pills/custom/pill13975-1/divalproex-sodium-extended-release.jpg)
![Divalproex sodium extended-release 250 mg M 177](https://www.drugs.com/images/pills/mtm/510790766_PB.jpg)
Divalproex Sodium Extended-Release
- Imprint
- M 177
- Strength
- 250 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
ammonia,
silicon dioxide,
dibutyl sebacate,
oleic acid,
polydextrose,
microcrystalline cellulose,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-0472 | Mylan Pharmaceuticals Inc. |
51079-0766 | UDL Laboratories Inc. |
Related images for "M 177"
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (505)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.